Log in to save to my catalogue

Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a c...

Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_02315310v1

Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

About this item

Full title

Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

Publisher

England: Elsevier Ltd

Journal title

Lancet neurology, 2018-10, Vol.17 (10), p.860-869

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Diagnosis of Alzheimer's disease in Down syndrome is challenging because of the absence of validated diagnostic biomarkers. We investigated the diagnostic performance of plasma and CSF biomarkers in this population.
We did a cross-sectional study of adults aged 18 years and older with Down syndrome enrolled in a population-based health plan in C...

Alternative Titles

Full title

Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_02315310v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_02315310v1

Other Identifiers

ISSN

1474-4422

E-ISSN

1474-4465

DOI

10.1016/S1474-4422(18)30285-0

How to access this item